3Clement LC, Liu G, Perez-Torres I, et al. Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int, 2007,72:337-347.
4Kawachi H. Miyauchi N, Suzuki K, et al. Role of podocyte slit diaphragm as a filtration barrier. Nephrology (Carlton), 2006,11:274-281.
5Ronco P, Debiec H. Target antigens and nephritogenic antibodiesin membranous nephropathy : of rats and men [ J ]. Semin Immunopathol, 2007,29(4) :445-458.
6Kerjaschki D. Molecular pathogenesis of membranous nephropathy [J]. Kidney Int, 1992,41(4) :1090-1105.
7Orlando RA, Kerjaschki D, kurrihara H. gp330 associates with a 4d.kD protein in the rat kidney to form the heymann nephritis antigenic complex [ J ]. Proc Natl Acad Sci USA, 1992,89 ( 15 ) :6698.
8Makker SP, Trarnontano A. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann hephritis-implications for the pathogenesis of idiopathic human membranous glomerulonephritis [ J]. J Pathol, 2006,210 (3) :282-287.
9Kerjaschki D,Farquhar MG.The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border[J].Proc Natl Acad Sci USA,1982,79(18):5557-5581.
10Kerjaschki D,Farquhar MG.Immunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats[J].J Exp Med,1983,157(2):667-686.
